JANX011
/ Janux Therapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 19, 2025
Study of JANX011 in Healthy Adult Volunteers to Assess Safety and Tolerability.
(clinicaltrials.gov)
- P1 | N=60 | Not yet recruiting | Sponsor: Janux Therapeutics
New P1 trial • Immunology
1 to 1
Of
1
Go to page
1